Skip to search formSkip to main contentSkip to account menu

Malignant neoplasm of ovary

Known as: ovarian ca, -- Ovarian Cancer, Ovarian cancer 
Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers… 
National Institutes of Health

Related topics

Related topics

37 relations
ADAM11 geneBIRC6 geneBIRC6 protein, humanBIRC6 wt Allele

Narrower (3)

Malignant Brenner TumorOvarian Carcinomaovarian adenocarcinoma

Broader (2)

Neoplasm, uncertain whether benign or malignantovarian neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Rethinking ovarian cancer: recommendations for improving outcomes
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are… 
Review
2008
Review
2008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
BACKGROUND Updated National Academy of Clinical Biochemistry (NACB) Laboratory Medicine Practice Guidelines for the use of tumor… 
Highly Cited
2005
Highly Cited
2005
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.
The cellular mechanisms underlying the increasing aggressiveness associated with ovarian cancer progression are poorly understood… 
Review
2003
Review
2003
Breast and ovarian cancer.
Breast and ovarian cancers are among the most common cancers in women. It is known that a woman is at higher risk for breast or… 
Highly Cited
2000
Highly Cited
2000
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.
BACKGROUND A randomized trial conducted by the Gynecologic Oncology Group (GOG, study #111) in the United States showed a better… 
Highly Cited
2000
Highly Cited
2000
Risks of leukaemia and solid tumours in individuals with Down's syndrome
Highly Cited
1995
Highly Cited
1995
Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome
Identification of hereditary non‐polyposis colorectal cancer (HNPCC) indicates theoretical life‐time risks of 50% for the… 
Highly Cited
1994
Highly Cited
1994
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline… 
Highly Cited
1993
Highly Cited
1993
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
Breast cancer is known to have an inherited component, consistent in some families with autosomal dominant inheritance; in such… 
Review
1991
Review
1991
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
In an effort to critically define the incidence and clinical characteristics of secondary responses to cisplatin-based therapy in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)